New Equilibrium Bioscience’s mission is to discover new medicines for life-threatening diseases with a focus on extending the health span of patients. We leverage our computational-experimental platform to discover lead drug candidates that regulate intrinsically disordered proteins implicated in cancers and neurodegenerative disorders.
Location: United States, Massachusetts, Boston
Employees: 11-50
Total raised: $10M
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | RA Capital... | racap.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.04.2021 | Seed | $10M | RA Capital... |
Mentions in press and media 3
| Date | Title | Description |
| 07.09.2021 | Meet Dr. Tony Kulesa, founder and Partner at Petri | Petri, which is funded by Pillar VC, focuses on helping scientists start companies Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times have changed! While there are more ... |
| 05.04.2021 | New Equilibrium Biosciences Raises $10M in Seed Funding | New Equilibrium Biosciences, a Cambridge, Mass.-based company that advances a rational drug design against intrinsically disordered proteins (IDPs), closed a $10m in seed funding. RA Capital Management made the investment. New Equilibrium p... |
| 31.03.2021 | New Equilibrium Bio raises $10 Million from RA Capital for AI-powered Quantum Chemistry | New Equilibrium, the pioneer in rational drug design against intrinsically disordered proteins (IDPs), has closed a $10 million seed from RA Capital Management. New Equilibrium’s platform reveals previously-undetectable opportunities for st... |